[PDF][PDF] Videoendoscopic analysis of nasal steroid distribution

R Weber, R Keerl, R Radziwill, B Schick, D Jaspersen… - …, 1999 - researchgate.net
Topical corticosteroids are one of the main pillars in the treatment of nasal polyps. The exact
topography of their intranasal deposition has not yet been adequately visualised. The …

Adherence to hospital discharge medication in patients with ischemic stroke: a prospective, interventional 2-phase study

C Hohmann, T Neumann-Haefelin, JM Klotz… - Stroke, 2013 - Am Heart Assoc
Background and Purpose—Communication between hospitals and primary care physicians
is essential for the continuity of care for patients being transferred from hospital to …

Drug-related problems in patients with ischemic stroke in hospital

C Hohmann, T Neumann-Haefelin, JM Klotz… - International journal of …, 2012 - Springer
Background Drug therapy is getting more complex, thus making it more challenging to
prescribe appropriate drug therapy. Accordingly, in clinical practice, a wide range of drug …

[HTML][HTML] Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept)

C Hohmann, R Radziwill, JM Klotz… - Health and quality of life …, 2010 - Springer
Background Health-related quality of life (HRQoL) after stroke is an important healthcare
measure. Pharmaceutical Care (PC) is an evolving concept to optimize drug-therapy …

Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life

C Hohmann, JM Klotz, R Radziwill, AH Jacobs… - Pharmacy world & …, 2009 - Springer
Objectives To improve patients health-related quality of life (HQL) after transient ischemic
attack (TIA) or ischemic stroke; to guarantee an effective secondary prevention; to increase …

Medicines optimization for patients with chronic kidney disease in the outpatient setting: the role of the clinical pharmacist

A Schütze, C Hohmann, M Haubitz… - … Journal of Pharmacy …, 2021 - academic.oup.com
Objectives Medicines optimization (MO) in patients with chronic kidney disease (CKD) is at
high risk at transition points of different ambulatory care levels such as nephrologists in …

Hormonal and pharmacological alteration of angiotensinogen secretion from rat hepatocytes

M Stuzmann, R Radziwill, K Komischke, C Klett… - … et Biophysica Acta (BBA …, 1986 - Elsevier
Isolated hepatocytes were prepared from rat liver by collagenase perfusion and density
gradient centrifugation. The hepatocyte preparation released angiotensinogen at a basal …

Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease

A Schütze, P Benöhr, M Haubitz, R Radziwill… - European Journal of …, 2023 - ejhp.bmj.com
Objectives Chronic kidney disease (CKD) is a common disorder all over the world.
Therapeutic goals are early detection of declining renal function and implementation of …

Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat

R Radziwill, M Stuzmann, U Hilgenfeldt… - European journal of …, 1986 - Elsevier
Chronic treatment with converting enzyme inhibitors induces a fall of plasma
angiotensinogen concentration, which is thought to result from increased consumption by …

Pharmaceutical care for a patient with ischemic stroke

C Hohmann, R Radziwill, A Walter, JM Klotz… - Medizinische …, 2008 - europepmc.org
A 61-year-old patient with a sudden numbness of the right arm and hand and signs of
amnestic aphasia is admitted to the stroke unit with the diagnosis of an acute ischemic …